Piperazine

Piperazine

SCHEMBL28333641

C1CNCCN1.CC(C)c1cc(-c2nnc(O)n2-c2ccc(N3CCNCC3)cc2)c(O)cc1O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 18/20 0.50
HSP90AA1 P07900 17/20 0.50
ADRB1 P08588 2/20 0.40
HSP90B1 P14625 1/20 0.38
TRAP1 Q12931 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15522088 0.99 HSP90AB1 (0.51) HSP90AB1HSP90AA1ADRB1HSP90B1TRAP1
SCHEMBL4783606 0.89 HSP90AB1 (0.54) HSP90AB1HSP90AA1HSP90B1TRAP1
SCHEMBL4743235 0.87 HSP90AB1 (0.53) HSP90AB1HSP90AA1HSP90B1TRAP1
Piperazine SCHEMBL28333614 0.86 HSP90AA1 (0.46) HSP90AB1HSP90AA1HSP90B1TRAP1
SCHEMBL4280050 0.86 HSP90AA1 (0.54) HSP90AB1HSP90AA1
Hydrochloric Acid SCHEMBL4787022 0.86 HSP90AB1 (0.52) HSP90AB1HSP90AA1HSP90B1TRAP1
SCHEMBL28333664 0.85 HSP90AB1 (0.43) HSP90AB1HSP90AA1
SCHEMBL30368851 0.85 HSP90AA1 (0.47) HSP90AB1HSP90AA1HSP90B1TRAP1
SCHEMBL15522473 0.85 HSP90AA1 (0.47) HSP90AB1HSP90AA1HSP90B1TRAP1
SCHEMBL4744640 0.84 HSP90AA1 (0.53) HSP90AB1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104470941-B targeted therapeutics 马德里加尔制药公司 2019-09-27 CN disclosed